CONSTANT LEVERAGE SHORT - PFIZER INC Share Price

Certificat

3ZLEB

NLBNPNL1M1T2

Market Closed - Euronext Paris 17:30:02 17/05/2024 BST
22.5 EUR +2.98% Intraday chart for CONSTANT LEVERAGE SHORT - PFIZER INC
Current month-44.15%
1 month-47.70%
Date Price Change
17/05/24 22.5 +2.98%
16/05/24 21.84 +1.53%
15/05/24 21.52 -9.73%
14/05/24 23.84 +1.00%
13/05/24 23.6 -4.59%

Real-time Euronext Paris

Last update May 17, 2024 at 05:30 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
3ZLEB
ISINNLBNPNL1M1T2
Date issued 21/01/2022
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 45.67
Lowest since issue 4.06
Spread 0.17
Spread %0.75%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92 USD
Average target price
31.94 USD
Spread / Average Target
+10.44%
Consensus
  1. Stock Market
  2. Certificates
  3. 3ZLEB Certificat